PONTE VEDRA BEACH, Fla. — The PGA TOUR and Astellas Pharma US, Inc. (“Astellas”), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., announced today a 3-year agreement in which Astellas will champion the PGA TOUR’s commitment to its new Women’s Initiative.